ABBC1

ABBC1 is a multi-ingredient nutraceutical composition developed by **AB Biotek** (a division of Associated British Foods) designed to enhance immune function through a process known as "trained immunity." The formulation consists of a synergistic combination of yeast-derived **beta-1,3/1,6-glucans**, inactivated **Saccharomyces cerevisiae**, and postbiotic-rich **selenium** and **zinc**. ABBC1 is primarily intended to prime the innate immune system, thereby improving the body's response to infections and enhancing the efficacy of vaccines, such as those for seasonal influenza and COVID-19. Clinical studies have also explored its potential as an adjunct therapy in allergic rhinitis and for improving metabolic parameters and sleep quality. The supplement works by interacting with pattern recognition receptors on immune cells, leading to epigenetic and metabolic reprogramming that results in a more robust and balanced immune response.

Brand names

ABB C1

Other names

ABBC1 postbiotic trained immunityABBC-1 postbiotic trained immunityABBC 1 postbiotic trained immunityyeast beta-glucan + Saccharomyces cerevisiae + selenium + zinc